close up of mother pouring cough syrup. blurred baby boy in background
The global pediatric drugs market is expected to expand significantly, growing from USD 115.6 billion in 2022 to an estimated USD 363.86 billion by 2032. This growth, at a compound annual growth rate (CAGR) of 12.2% from 2023 to 2032, is primarily driven by the rising prevalence of pediatric diseases and the increasing number of children worldwide in need of specialized treatments.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5074
The growing use of off-label drugs in children highlights the need for medications specifically designed for their unique needs. This, combined with rising health issues such as obesity, asthma, and diabetes, is fueling growth in the pediatric drugs market.
As awareness increases among parents and healthcare providers, the demand for tailored pediatric medications rises. Governments are supporting this trend with incentives like market exclusivity, driving further research and innovation. The expanding market is crucial for improving children’s health globally.
Route of Administration Boosts Pediatric Drugs Market Growth
The pediatric drugs market is mainly driven by the oral administration segment, which dominated in 2020. Oral medications are preferred due to their non-invasive nature, ease of administration, and improved compliance, with lower risks of side effects and drug interactions.
Distribution Channels Fuel Market Expansion
Hospital, retail, and online pharmacies all play crucial roles in the growth of the pediatric drugs market. Hospital pharmacies ensure a steady supply and guide treatment plans, while retail pharmacies offer easy access and support for medication adherence. Online pharmacies improve accessibility, particularly for remote families, by providing a range of medications and telemedicine services. Together, these channels help meet children’s healthcare needs effectively.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/pediatric-drugs-market
Access exclusive insight now @ https://www.towardshealthcare.com/price/5074
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More